Caxton Associates (UK)’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$720K Sell
41,397
-18,072
-30% -$325K 0.02% 447
2025
Q4
$1.04M Buy
+59,469
New +$968K 0.02% 347

Other funds holding MXL

Caxton Associates (UK)'s MXL Position: Q1 2026 in Review

Caxton Associates (UK) reduced its MaxLinear (MXL) stake by 30% in Q1 2026, selling an estimated $325K and leaving 41,397 shares worth $720K. The position accounts for 0.02% of the portfolio, ranked #447.

Caxton Associates (UK) first reported a position in MXL in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.04M in Q4 2025. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.

  • Caxton Associates (UK) held 41,397 shares of MaxLinear worth $720K as of Q1 2026.
  • Caxton Associates (UK) sold 18,072 MaxLinear shares in Q1 2026, an estimated $325K.
  • MaxLinear made up 0.02% of Caxton Associates (UK)'s portfolio in Q1 2026, its #447 holding.
  • Caxton Associates (UK) first reported a position in MaxLinear in Q4 2025 and has held it in 2 quarters since.
  • Caxton Associates (UK)'s MaxLinear position peaked at $1.04M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.